Novartis Ag ADR (NVS)

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today

By Dana Blankenhorn, InvestorPlace Contributor Jan 2, 2024

VYGR stock is in focus as analysts expect more pharma deals in 2024, although some think these deals will be sunk by the Biden administration.

3 Healthcare Stocks to Pick Up Before the Year-End Rally

By Muslim Farooque, InvestorPlace Contributor Nov 28, 2023

Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending

7 Undervalued Stocks to Buy Before Everyone Else

By Chandler Capital, InvestorPlace Contributor Oct 26, 2023

Buy these undervalued stocks while they trade at a significant discount compared to their intrinsic valuations.

7 Healthcare Stocks to invest in for a Healthy Future

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Oct 20, 2023

Healthcare stocks may be one of the few winning sectors considering today's economic uncertainty and market turns. Here are the winners.

SDZNY Stock: 7 Things to Know as Novartis Spinoff Sandoz Starts Trading Today

By William White, InvestorPlace Writer Oct 4, 2023

Sandoz (SDZNY) stock is a hot topic among traders on Wednesday as the company starts trading after a spinoff from Novartis.

NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff

By William White, InvestorPlace Writer Sep 15, 2023

Novartis (NVS) stock is rising higher on Friday after the company announced approval for the spinoff of its generic drugs business Sandoz.

The 7 Best Dividend Stocks to Protect Your Portfolio From Global Chaos

By Josh Enomoto, InvestorPlace Contributor Jul 24, 2023

With global events only rising in entropy, investors ought to consider these best dividend stocks for portfolio protection.

7 Top Growth Stocks to Watch for H2 2023

By Louis Navellier and the InvestorPlace Research Staff Jun 29, 2023

Many growth stocks still haven't completely recovered from their 2022 losses, so they have plenty of opportunities to do so in H2 2023.

Why Is AVROBIO (AVRO) Stock Up 83% Today?

By William White, InvestorPlace Writer May 22, 2023

AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS).

3 Drug Stocks With Promising Pipelines for 2023

By Alex Sirois, InvestorPlace Contributor Jan 23, 2023

These 3 drug stocks with promising pipelines are in position to reward investors in 2023 due to multiple factors.

3 Biotech Stocks Smart Investors Should Be Buying Up Now

By Chris MacDonald, InvestorPlace Contributor Nov 24, 2022

These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.

7 Safe Havens All Investors Should Have Exposure to in 2022

By Chris Lau, InvestorPlace Contributor Sep 22, 2022

Few stocks with deep value and growth prospects offer upside and safe havens for investors, with those picks the exception.

3 Stocks That Could Rocket on Biden’s Cancer Moonshot

By Will Ashworth, InvestorPlace Contributor Sep 20, 2022

Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.

6 Dividend Stocks With High Yields and Low P/E Ratios

By Mark R. Hake, CFA May 23, 2022

6 Dividend stocks with high yields and low P/E ratios. These 6 dividend stocks have yields greater than 2.5% and P/E ratios lower than 16x with a positive earnings growth forecast for 2023.

3 Undervalued Stocks to Buy Before You Sell in May and Go Away

By Tezcan Gecgil, InvestorPlace Contributor May 13, 2022

If you really decide to sell in May and go away, you may miss out some profits from these undervalued stocks to buy.

7 Drug Stocks to Consider After the Viatris Plunge

By Thomas Niel, InvestorPlace Contributor Mar 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

7 Best Long-Term Stocks to Buy and Hold for the Next Decade

By Chris MacDonald, InvestorPlace Contributor Jan 13, 2022

These seven long-term stocks are among the best picks for truly long-term investors looking for companies to hold for the next decade.

AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today

By William White, InvestorPlace Writer Dec 2, 2021

Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor Nov 30, 2021

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Novartis AG (Six Swiss: CH:NOVN) and AstraZeneca (GB:AZN)

From TipRanks Apr 6, 2024

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stryker (SYK – Research Report), Novartis AG (CH:NOV...

Novartis Ag ADR (NVS)

NVS Stock Earnings: Novartis Beats EPS, Beats Revenue for Q1 2024

Novartis Layoffs 2024: What to Know About the Latest NVS Job Cuts

Harnessing AI for Drug Discovery: Top 3 Stocks to Watch

3 Stocks Primed for Exponential Returns by 2034

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novartis Ag ADR (NVS)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVS Stock Predictions, Articles, and Novartis Ag ADR News

Subscriber Sign in